Sponsor Pipeline

vTv Therapeutics Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
0
Recruiting
1
Phase 3
2
Disease Areas
4
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-29 NCT06334133
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes		 Enrollment closed, study ongoing
2026-07-29 NCT06334133
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes		 Trial sites reduced: 61 -> 52 locations
2026-07-29 NCT06334133
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes		 date change Primary completion pushed: 2026-09 -> 2027-04
2026-07-29 NCT06334133
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes		 date change Completion pushed: 2026-10 -> 2027-05
Active Trials by Phase
Phase 3
1
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06334133 Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes Diabetes Mellitus, Type 1 Active, Not Recruiting
Phase 2
NCT07616206 Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes Who… Type 1 Diabetes (T1D) Not Yet Recruiting
Disease Areas
Diabetes (2) Type 1 Diabetes (1)
Get alerts when vTv Therapeutics's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free